{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T14:55:24Z","timestamp":1776005724617,"version":"3.50.1"},"reference-count":65,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,6,30]],"date-time":"2015-06-30T00:00:00Z","timestamp":1435622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Cell Commun. Signal."],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s12079-015-0293-7","type":"journal-article","created":{"date-parts":[[2015,6,29]],"date-time":"2015-06-29T02:48:26Z","timestamp":1435546106000},"page":"347-352","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["WT1 expression is increased in primary fibroblasts derived from Dupuytren\u2019s disease tissues"],"prefix":"10.1002","volume":"9","author":[{"given":"Justin","family":"Crawford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Raykha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daevina","family":"Charles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing Siang","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David B.","family":"O\u2019Gorman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,6,30]]},"reference":[{"key":"293_CR1","first-page":"329","volume":"151","author":"BA Alman","year":"1997","unstructured":"Alman BA, Li C, Pajerski ME, Diaz-Cano S, Wolfe HJ (1997) Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am J Pathol 151:329\u2013334","journal-title":"Am J Pathol"},{"key":"293_CR2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0363-5023(96)80102-X","volume":"21","author":"MA Badalamente","year":"1996","unstructured":"Badalamente MA, Sampson SP, Hurst LC, Dowd A, Miyasaka K (1996) The role of transforming growth factor beta in Dupuytren\u2019s disease. J Hand Surg [Am] 21:210\u2013215","journal-title":"J Hand Surg [Am]"},{"key":"293_CR3","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/1521-1878(200011)22:11<961::AID-BIES1>3.0.CO;2-T","volume":"22","author":"N Barker","year":"2000","unstructured":"Barker N, Clevers H (2000) Catenins, Wnt signaling and cancer. Bioessays 22:961\u2013965","journal-title":"Bioessays"},{"key":"293_CR4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000163879","volume":"62","author":"A Berndt","year":"1994","unstructured":"Berndt A, Kosmehl H, Katenkamp D, Tauchmann V (1994) Appearance of the myofibroblastic phenotype in Dupuytren\u2019s disease is associated with a fibronectin, laminin, collagen type IV and tenascin extracellular matrix. Pathobiology 62:55\u201358","journal-title":"Pathobiology"},{"key":"293_CR5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1126\/science.1321494","volume":"257","author":"WA Bickmore","year":"1992","unstructured":"Bickmore WA, Oghene K, Little MH, Seawright A, van Heyningen V, Hastie ND (1992) Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript. Science 257:235\u2013237","journal-title":"Science"},{"key":"293_CR6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0266-7681(03)00135-9","volume":"28","author":"MA Bisson","year":"2003","unstructured":"Bisson MA, McGrouther DA, Mudera V, Grobbelaar AO (2003) The different characteristics of Dupuytren\u2019s disease fibroblasts derived from either nodule or cord: expression of alpha-smooth muscle actin and the response to stimulation by TGF-beta1. J Hand Surg (Br) 28:351\u2013356","journal-title":"J Hand Surg (Br)"},{"key":"293_CR7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jss.2006.07.026","volume":"138","author":"E Bowley","year":"2007","unstructured":"Bowley E, O\u2019Gorman DB, Gan BS (2007) Beta-catenin signaling in fibroproliferative disease. J Surg Res 138:141\u2013150","journal-title":"J Surg Res"},{"key":"293_CR8","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1158\/1541-7786.MCR-08-0002","volume":"6","author":"KW Brown","year":"2008","unstructured":"Brown KW, Power F, Moore B, Charles AK, Malik KT (2008) Frequency and timing of loss of imprinting at 11p13 and 11p15 in Wilms\u2019 tumor development. Mol Cancer Res 6:1114\u20131123","journal-title":"Mol Cancer Res"},{"key":"293_CR9","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jhsa.2005.05.008","volume":"30","author":"NW Bulstrode","year":"2005","unstructured":"Bulstrode NW, Jemec B, Smith PJ (2005) The complications of Dupuytren\u2019s contracture surgery. J Hand Surg [Am] 30:1021\u20131025","journal-title":"J Hand Surg [Am]"},{"key":"293_CR10","doi-asserted-by":"crossref","unstructured":"Capstick R, Bragg T, Giele H Furniss D (2013) Sibling recurrence risk in Dupuytren\u2019s disease. J Hand Surg Eur 38:424\u20139","DOI":"10.1177\/1753193412453359"},{"key":"293_CR11","doi-asserted-by":"crossref","first-page":"7562","DOI":"10.1073\/pnas.93.15.7562","volume":"93","author":"A Caricasole","year":"1996","unstructured":"Caricasole A, Duarte A, Larsson SH, Hastie ND, Little M, Holmes G, Todorov I, Ward A (1996) RNA binding by the Wilms tumor suppressor zinc finger proteins. Proc Natl Acad Sci U S A 93:7562\u20137566","journal-title":"Proc Natl Acad Sci U S A"},{"key":"293_CR12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1242\/jcs.1995.Supplement_19.14","volume":"19","author":"JP Charlieu","year":"1995","unstructured":"Charlieu JP, Larsson S, Miyagawa K, van Heyningen V, Hastie ND (1995) Does the Wilms\u2019 tumour suppressor gene, WT1, play roles in both splicing and transcription? J Cell Sci Suppl 19:95\u201399","journal-title":"J Cell Sci Suppl"},{"key":"293_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0363-5023(78)80112-9","volume":"3","author":"HF Chiu","year":"1978","unstructured":"Chiu HF, McFarlane RM (1978) Pathogenesis of Dupuytren\u2019s contracture: a correlative clinical- pathological study. J Hand Surg [Am] 3:1\u201310","journal-title":"J Hand Surg [Am]"},{"key":"293_CR14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1155\/2007\/363464","volume":"23","author":"H Cui","year":"2007","unstructured":"Cui H (2007) Loss of imprinting of IGF2 as an epigenetic marker for the risk of human cancer. Dis Markers 23:105\u2013112","journal-title":"Dis Markers"},{"key":"293_CR15","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1677\/ERC-07-0161","volume":"14","author":"JW Groot de","year":"2007","unstructured":"de Groot JW, Rikhof B, van Doorn J, Bilo HJ, Alleman MA, Honkoop AH, van der Graaf WT (2007) Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases. Endocr Relat Cancer 14:979\u2013993","journal-title":"Endocr Relat Cancer"},{"key":"293_CR16","first-page":"316","volume":"76","author":"I Degreef","year":"2012","unstructured":"Degreef I, De Smet L (2012) A high prevalence of Dupuytren\u2019s disease in Flanders. Acta Orthop Belg 76:316\u2013320","journal-title":"Acta Orthop Belg"},{"key":"293_CR17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11552-010-9306-4","volume":"6","author":"DB Dibenedetti","year":"2012","unstructured":"Dibenedetti DB, Nguyen D, Zografos L, Ziemiecki R, Zhou X (2012) Prevalence, incidence, and treatments of Dupuytren\u2019s disease in the United States: results from a population-based study. Hand (N Y) 6:149\u2013158","journal-title":"Hand (N Y)"},{"key":"293_CR18","unstructured":"Dohi S, Ohno S, Ohno Y, Takakura M, Kyo S, Soma G, Sugiyama H, Inoue M (2011) WT1 peptide vaccine stabilized intractable ovarian cancer patient for one year: a case report. Anticancer Res 31:2441\u20132445"},{"key":"293_CR19","doi-asserted-by":"crossref","unstructured":"Dubrovsky L, Pankov D, Brea EJ, Dao T, Scott A, Yan S, O\u2019Reilly RJ, Liu C, Scheinberg DA (2014) A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemias. Blood 123:3296\u20133304","DOI":"10.1182\/blood-2014-01-549022"},{"key":"293_CR20","first-page":"222","volume":"2","author":"G Dupuytren","year":"1834","unstructured":"Dupuytren G (1834) Permanent retraction of the fingers, produced by an affection of the palmar fascia. Lancet 2:222\u2013225","journal-title":"Lancet"},{"key":"293_CR21","first-page":"326","volume":"90","author":"AH Elmaagacli","year":"2005","unstructured":"Elmaagacli AH, Koldehoff M, Peceny R, Klein-Hitpass L, Ottinger H, Beelen DW, Opalka B (2005) WT1 and BCR-ABL specific small interfering RNA have additive effects in the induction of apoptosis in leukemic cells. Haematologica 90:326\u2013334","journal-title":"Haematologica"},{"key":"293_CR22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0266-7681(03)00013-5","volume":"28","author":"G Foucher","year":"2003","unstructured":"Foucher G, Medina J, Navarro R (2003) Percutaneous needle aponeurotomy: complications and results. J Hand Surg (Br) 28:427\u2013431","journal-title":"J Hand Surg (Br)"},{"key":"293_CR23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/path.2366","volume":"215","author":"R Fukuzawa","year":"2008","unstructured":"Fukuzawa R, Anaka MR, Heathcott RW, McNoe LA, Morison IM, Perlman EJ, Reeve AE (2008) Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes. J Pathol 215:377\u2013387","journal-title":"J Pathol"},{"key":"293_CR24","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/gcc.20572","volume":"47","author":"M Haruta","year":"2008","unstructured":"Haruta M, Arai Y, Sugawara W, Watanabe N, Honda S, Ohshima J, Soejima H, Nakadate H, Okita H, Hata J et al (2008) Duplication of paternal IGF2 or loss of maternal IGF2 imprinting occurs in half of Wilms tumors with various structural WT1 abnormalities. Genes Chromosome Cancer 47:712\u2013727","journal-title":"Genes Chromosome Cancer"},{"key":"293_CR25","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.ajpath.2012.05.026","volume":"181","author":"JH Heaton","year":"2013","unstructured":"Heaton JH, Wood MA, Kim AC, Lima LO, Barlaskar FM, Almeida MQ, Fragoso MC, Kuick R, Lerario AM, Simon DP et al (2013) Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and beta-catenin. Am J Pathol 181:1017\u20131033","journal-title":"Am J Pathol"},{"key":"293_CR26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/cncr.10482","volume":"96","author":"JL Hecht","year":"2002","unstructured":"Hecht JL, Lee BH, Pinkus JL, Pinkus GS (2002) The value of Wilms tumor susceptibility gene 1 in cytologic preparations as a marker for malignant mesothelioma. Cancer 96:105\u2013109","journal-title":"Cancer"},{"key":"293_CR27","first-page":"621","volume":"16","author":"SM Hewitt","year":"1996","unstructured":"Hewitt SM, Saunders GF (1996) Differentially spliced exon 5 of the Wilms\u2019 tumor gene WT1 modifies gene function. Anticancer Res 16:621\u2013626","journal-title":"Anticancer Res"},{"key":"293_CR28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2474-4-16","volume":"4","author":"JC Howard","year":"2003","unstructured":"Howard JC, Varallo VM, Ross DC, Roth JH, Faber KJ, Alman B, Gan BS (2003) Elevated levels of beta-catenin and fibronectin in three-dimensional collagen cultures of Dupuytren\u2019s disease cells are regulated by tension in vitro. BMC Musculoskelet Disord 4:16","journal-title":"BMC Musculoskelet Disord"},{"key":"293_CR29","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jss.2004.01.013","volume":"117","author":"JC Howard","year":"2004","unstructured":"Howard JC, Varallo VM, Ross DC, Faber KJ, Roth JH, Seney S, Gan BS (2004) Wound healing-associated proteins Hsp47 and fibronectin are elevated in Dupuytren\u2019s contracture. J Surg Res 117:232\u2013238","journal-title":"J Surg Res"},{"key":"293_CR30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00694924","volume":"405","author":"H Iwasaki","year":"1984","unstructured":"Iwasaki H, Muller H, Stutte HJ, Brennscheidt U (1984) Palmar fibromatosis (Dupuytren\u2019s contracture). Ultrastructural and enzyme histochemical studies of 43 cases. Virchows Arch A Pathol Anat Histopathol 405:41\u201353","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"293_CR31","doi-asserted-by":"crossref","unstructured":"Jacobs DI, Mao Y, Fu A, Kelly WK, Zhu Y (2013) Dysregulated methylation at imprinted genes in prostate tumor tissue detected by methylation microarray. BMC Urol 13:37","DOI":"10.1186\/1471-2490-13-37"},{"key":"293_CR32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bjps.2012.08.019","volume":"66","author":"HJ Kan","year":"2015","unstructured":"Kan HJ, Verrijp FW, Huisstede BM, Hovius SE, van Nieuwenhoven CA, Selles RW (2015) The consequences of different definitions for recurrence of Dupuytren\u2019s disease. J Plast Reconstr Aesthet Surg 66:95\u2013103","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"293_CR33","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1096\/fj.13-236828","volume":"28","author":"S Karki","year":"2015","unstructured":"Karki S, Surolia R, Hock TD, Guroji P, Zolak JS, Duggal R, Ye T, Thannickal VJ, Antony VB (2015) Wilms\u2019 tumor 1 (Wt1) regulates pleural mesothelial cell plasticity and transition into myofibroblasts in idiopathic pulmonary fibrosis. Faseb J 28:1122\u20131131","journal-title":"Faseb J"},{"key":"293_CR34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng0396-329","volume":"12","author":"D Kennedy","year":"1996","unstructured":"Kennedy D, Ramsdale T, Mattick J, Little M (1996) An RNA recognition motif in Wilms\u2019 tumour protein (WT1) revealed by structural modelling. Nat Genet 12:329\u2013331","journal-title":"Nat Genet"},{"key":"293_CR35","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1006\/excr.2000.5131","volume":"264","author":"SB Lee","year":"2001","unstructured":"Lee SB, Haber DA (2001) Wilms tumor and the WT1 gene. Exp Cell Res 264:74\u201399","journal-title":"Exp Cell Res"},{"key":"293_CR36","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0092-8674(00)80053-7","volume":"98","author":"SB Lee","year":"1999","unstructured":"Lee SB, Huang K, Palmer R, Truong VB, Herzlinger D, Kolquist KA, Wong J, Paulding C, Yoon SK, Gerald W et al (1999) The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin. Cell 98:663\u2013673","journal-title":"Cell"},{"key":"293_CR37","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.ygyno.2006.06.006","volume":"103","author":"L Lu","year":"2006","unstructured":"Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Puopolo M, Schwartz P, Yu H (2006) Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer. Gynecol Oncol 103:990\u2013995","journal-title":"Gynecol Oncol"},{"key":"293_CR38","doi-asserted-by":"crossref","unstructured":"Magro G, Salvatorelli L, Vecchio GM, Musumeci G, Rita A, Parenti R (2014) Cytoplasmic expression of Wilms tumor transcription factor-1 (WT1): a useful immunomarker for young-type fibromatoses and infantile fibrosarcoma. Acta Histochem 116:1134\u201340","DOI":"10.1016\/j.acthis.2014.05.010"},{"key":"293_CR39","first-page":"185","volume":"142","author":"G Magro","year":"1997","unstructured":"Magro G, Fraggetta F, Colombatti A, Lanzafame S (1997) Myofibroblasts and extracellular matrix glycoproteins in palmar fibromatosis. Gen Diagn Pathol 142:185\u2013190","journal-title":"Gen Diagn Pathol"},{"key":"293_CR40","first-page":"2356","volume":"60","author":"K Malik","year":"2000","unstructured":"Malik K, Salpekar A, Hancock A, Moorwood K, Jackson S, Charles A, Brown KW (2000) Identification of differential methylation of the WT1 antisense regulatory region and relaxation of imprinting in Wilms\u2019 tumor. Cancer Res 60:2356\u20132360","journal-title":"Cancer Res"},{"key":"293_CR41","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/PAT.0b013e3283463575","volume":"43","author":"R Md Zin","year":"2013","unstructured":"Md Zin R, Murch A, Charles A (2013) Pathology, genetics and cytogenetics of Wilms\u2019 tumour. Pathology 43:302\u2013312","journal-title":"Pathology"},{"key":"293_CR42","doi-asserted-by":"crossref","first-page":"852","DOI":"10.3390\/v1030852","volume":"1","author":"P Merle","year":"2009","unstructured":"Merle P, Trepo C (2009) Molecular mechanisms underlying hepatocellular carcinoma. Viruses 1:852\u2013872","journal-title":"Viruses"},{"key":"293_CR43","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1093\/hmg\/6.13.2243","volume":"6","author":"K Mitsuya","year":"1997","unstructured":"Mitsuya K, Sui H, Meguro M, Kugoh H, Jinno Y, Niikawa N, Oshimura M (1997) Paternal expression of WT1 in human fibroblasts and lymphocytes. Hum Mol Genet 6:2243\u20132246","journal-title":"Hum Mol Genet"},{"key":"293_CR44","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P","volume":"21","author":"PJ Morin","year":"1999","unstructured":"Morin PJ (1999) beta-catenin signaling and cancer. Bioessays 21:1021\u20131030","journal-title":"Bioessays"},{"key":"293_CR45","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1139\/o06-065","volume":"84","author":"AA Morrison","year":"2006","unstructured":"Morrison AA, Venables JP, Dellaire G, Ladomery MR (2006) The Wilms tumour suppressor protein WT1 (+KTS isoform) binds alpha-actinin 1 mRNA via its zinc-finger domain. Biochem Cell Biol 84:789\u2013798","journal-title":"Biochem Cell Biol"},{"key":"293_CR46","first-page":"55","volume":"1785","author":"AA Morrison","year":"2008","unstructured":"Morrison AA, Viney RL, Ladomery MR (2008) The post-transcriptional roles of WT1, a multifunctional zinc-finger protein. Biochim Biophys Acta 1785:55\u201362","journal-title":"Biochim Biophys Acta"},{"key":"293_CR47","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/modpathol.3800588","volume":"19","author":"S Nakatsuka","year":"2006","unstructured":"Nakatsuka S, Oji Y, Horiuchi T, Kanda T, Kitagawa M, Takeuchi T, Kawano K, Kuwae Y, Yamauchi A, Okumura M et al (2006) Immunohistochemical detection of WT1 protein in a variety of cancer cells. Mod Pathol 19:804\u2013814","journal-title":"Mod Pathol"},{"key":"293_CR48","doi-asserted-by":"crossref","unstructured":"Nishida S, Koido S, Takeda Y, Homma S, Komita H, Takahara A, Morita S, Ito T, Morimoto S, Hara K et al (2014) Wilms tumor gene (WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic cancer. J Immunother 37:105\u201314","DOI":"10.1097\/CJI.0000000000000020"},{"key":"293_CR49","first-page":"1691","volume":"29","author":"S Ohno","year":"2009","unstructured":"Ohno S, Dohi S, Ohno Y, Kyo S, Sugiyama H, Suzuki N, Inoue M (2009) Immunohistochemical detection of WT1 protein in endometrial cancer. Anticancer Res 29:1691\u20131695","journal-title":"Anticancer Res"},{"key":"293_CR50","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/1568009023334088","volume":"2","author":"Y Oka","year":"2002","unstructured":"Oka Y, Tsuboi A, Elisseeva OA, Udaka K, Sugiyama H (2002) WT1 as a novel target antigen for cancer immunotherapy. Curr Cancer Drug Targets 2:45\u201354","journal-title":"Curr Cancer Drug Targets"},{"key":"293_CR51","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.2174\/092986706777935104","volume":"13","author":"Y Oka","year":"2006","unstructured":"Oka Y, Tsuboi A, Kawakami M, Elisseeva OA, Nakajima H, Udaka K, Kawase I, Oji Y, Sugiyama H (2006) Development of WT1 peptide cancer vaccine against hematopoietic malignancies and solid cancers. Curr Med Chem 13:2345\u20132352","journal-title":"Curr Med Chem"},{"issue":"87\u201396","key":"293_CR52","first-page":"vii","volume":"15","author":"GM Rayan","year":"1999","unstructured":"Rayan GM (1999) Clinical presentation and types of Dupuytren\u2019s disease. Hand Clin 15(87\u201396):vii","journal-title":"Hand Clin"},{"key":"293_CR53","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.bbadis.2013.04.018","volume":"1832","author":"C Raykha","year":"2013","unstructured":"Raykha C, Crawford J, Gan BS, Fu P, Bach LA, O\u2019Gorman DB (2013) IGF-II and IGFBP-6 regulate cellular contractility and proliferation in Dupuytren\u2019s disease. Biochim Biophys Acta 1832:1511\u20131519","journal-title":"Biochim Biophys Acta"},{"key":"293_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00129039-200503000-00001","volume":"13","author":"NJ Sebire","year":"2005","unstructured":"Sebire NJ, Gibson S, Rampling D, Williams S, Malone M, Ramsay AD (2005) Immunohistochemical findings in embryonal small round cell tumors with molecular diagnostic confirmation. Appl Immunohistochem Mol Morphol 13:1\u20135","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"293_CR55","doi-asserted-by":"crossref","first-page":"25313","DOI":"10.1074\/jbc.M203158200","volume":"277","author":"S Shah","year":"2002","unstructured":"Shah S, Pishvaian MJ, Easwaran V, Brown PH, Byers SW (2002) The role of cadherin, beta-catenin, and AP-1 in retinoid-regulated carcinoma cell differentiation and proliferation. J Biol Chem 277:25313\u201325322","journal-title":"J Biol Chem"},{"key":"293_CR56","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00004347-200004000-00010","volume":"19","author":"M Shimizu","year":"2000","unstructured":"Shimizu M, Toki T, Takagi Y, Konishi I, Fujii S (2000) Immunohistochemical detection of the Wilms\u2019 tumor gene (WT1) in epithelial ovarian tumors. Int J Gynecol Pathol 19:158\u2013163","journal-title":"Int J Gynecol Pathol"},{"key":"293_CR57","unstructured":"Shirakata T, Oka Y, Nishida S, Hosen N, Tsuboi A, Oji Y, Murao A, Tanaka H, Nakatsuka S, Inohara H et al (2012) WT1 peptide therapy for a patient with chemotherapy-resistant salivary gland cancer. Anticancer Res 32:1081\u20131085"},{"key":"293_CR58","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0016-5085(98)70428-7","volume":"114","author":"P Singh","year":"1998","unstructured":"Singh P, Dai B, Given RL, Lu X, Holthuizen PE (1998) Differential activation of IGF-II promoters P3 and P4 in Caco-2 cells during growth and differentiation. Gastroenterology 114:1221\u20131229","journal-title":"Gastroenterology"},{"key":"293_CR59","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/18884","volume":"398","author":"O Tetsu","year":"1999","unstructured":"Tetsu O, McCormick F (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422\u2013426","journal-title":"Nature"},{"key":"293_CR60","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0363-5023(86)80143-5","volume":"11","author":"JJ Tomasek","year":"1986","unstructured":"Tomasek JJ, Schultz RJ, Episalla CW, Newman SA (1986) The cytoskeleton and extracellular matrix of the Dupuytren\u2019s disease \u201cmyofibroblast\u201d: an immunofluorescence study of a nonmuscle cell type. J Hand Surg [Am] 11:365\u2013371","journal-title":"J Hand Surg [Am]"},{"key":"293_CR61","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.2106\/00004623-198769090-00013","volume":"69","author":"JJ Tomasek","year":"1987","unstructured":"Tomasek JJ, Schultz RJ, Haaksma CJ (1987) Extracellular matrix-cytoskeletal connections at the surface of the specialized contractile fibroblast (myofibroblast) in Dupuytren disease. J Bone Joint Surg Am 69:1400\u20131407","journal-title":"J Bone Joint Surg Am"},{"key":"293_CR62","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1038\/sj.onc.1206415","volume":"22","author":"VM Varallo","year":"2003","unstructured":"Varallo VM, Gan BS, Seney S, Ross DC, Roth JH, Richards RS, McFarlane RM, Alman B, Howard JC (2003) Beta-catenin expression in Dupuytren\u2019s disease: potential role for cell-matrix interactions in modulating beta-catenin levels in vivo and in vitro. Oncogene 22:3680\u20133684","journal-title":"Oncogene"},{"issue":"20","key":"293_CR63","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1016\/j.yexcr.2009.07.015","volume":"315","author":"L Vi","year":"2009","unstructured":"Vi L, Feng L, Zhu RD, Wu Y, Satish L, Gan BS, O'Gorman DB (2009) Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren\u2019s disease and adjacent palmar fascia cells. Exp Cell Res 315(20):3574\u20133586","journal-title":"Exp Cell Res"},{"key":"293_CR64","doi-asserted-by":"crossref","unstructured":"Watt AJ, Curtin CM, Hentz VR (2012) Collagenase injection as nonsurgical treatment of Dupuytren\u2019s disease: 8-year follow-up. J Hand Surg Am 35:534\u20139, 539 e1","DOI":"10.1016\/j.jhsa.2010.01.003"},{"key":"293_CR65","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2559.2007.02843.x","volume":"51","author":"M Wilsher","year":"2007","unstructured":"Wilsher M, Cheerala B (2007) WT1 as a complementary marker of malignant melanoma: an immunohistochemical study of whole sections. Histopathology 51:605\u2013610","journal-title":"Histopathology"}],"container-title":["Journal of Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12079-015-0293-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12079-015-0293-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12079-015-0293-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T19:04:25Z","timestamp":1702667065000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12079-015-0293-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,30]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["293"],"URL":"https:\/\/doi.org\/10.1007\/s12079-015-0293-7","relation":{},"ISSN":["1873-9601","1873-961X"],"issn-type":[{"value":"1873-9601","type":"print"},{"value":"1873-961X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,30]]}}}